ArticlePharmaceutical research2017
Why Have Clinical Trials of Antioxidants to Prevent Neurodegeneration Failed? - A Cellular Investigation of Novel Phenothiazine-Type Antioxidants Reveals Competing Objectives for Pharmaceutical Neuroprotection.
Maike J Ohlow et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it